Reasons to choose a long acting antipsychotic and tolerability

被引：0
|
作者：
Martinez Molina, I. [1 ]
Suarez de Venegas, N. Gomez-Coronado [1 ]
Blanco Ramon, P. [1 ]
机构：
[1] Hosp Univ Virgen del Rocio, Salud Mental, Seville, Spain
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.1604
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EV1274
引用
收藏
页码：S822 / S822
页数：1
相关论文
共 50 条
  • [1] A review of the efficacy and tolerability of antipsychotic long-acting injections
    Whyte, Allison
    Parker, Caroline
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2016, 20 (04) : 22 - 28
  • [2] Long-acting antipsychotic injectables in patients under compulsory outpatient treatment: the right to choose
    Pinto, C. Mota
    Klut, C.
    Heitor, M. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S389 - S389
  • [3] Experience or recommendations? The reasons of psychiatrists to choose an antipsychotic or another in schizophrenia
    Laforgue, E. J.
    Bresdin, V.
    Istvan, M.
    Grall-Bronnec, M.
    Victorri-Vigneau, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 203 - 203
  • [4] Treatment of first-episode psychosis: Efficacy and tolerability of a long-acting typical antipsychotic
    Chilliza, B.
    Schoeman, R.
    Emsley, R.
    Oosthuizen, P.
    Koen, L.
    Niehaus, D.
    Hawkridge, S.
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2008, 14 (03) : 94 - 94
  • [5] Treatment of first-episode psychosis: efficacy and tolerability of a long-acting typical antipsychotic
    Chiliza, B.
    Schoeman, R.
    Emsley, R.
    Oosthuizen, P.
    Koen, L.
    Niehaus, D.
    Hawkridge, S.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A81 - A81
  • [6] Long-Acting Antipsychotic Medications
    Baweja, Raman
    Sedky, Karim
    Lippmann, Steven
    CURRENT DRUG TARGETS, 2012, 13 (04) : 555 - 560
  • [7] Antipsychotic long-acting injections
    O'Connor, Nick
    AUSTRALASIAN PSYCHIATRY, 2013, 21 (02) : 176 - 177
  • [8] Antipsychotic Long-acting Injections
    Livingston, Martin
    PSYCHIATRIC BULLETIN, 2011, 35 (11): : 438 - 439
  • [9] Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic in first-episode schizophrenic patients
    Petric, D.
    Racki, V.
    Graovac, M.
    Kastelan, A.
    Grahovac, T.
    Vucic-Peitl, M.
    Franciskovic, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 150 - 151
  • [10] Duration of long-acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia
    Kishi, Taro
    Sakuma, Kenji
    Okuya, Makoto
    Hatano, Masakazu
    Iwata, Nakao
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (07) : 240 - 241
12345